-
The Evolving Landscape of Heart Failure Therapies
Neeta Ratanghayra
January 31, 2024
Heart failure (HF) is a leading cause of disability worldwide and has a major impact on the global economy and healthcare systems.
-
What's happening in HF therapies
Neeta Ratanghayra
January 02, 2024
Heart failure (HF) is a leading cause of disability worldwide and has a major impact on the global economy and healthcare systems.The severity of the disease warrants the development of innovative solutions to address the current treatment gap.
-
FDA Approves Treatment for Wider Range of Patients with Heart Failure
FDA
February 25, 2022
The U.S. Food and Drug Administration approved Jardiance (empagliflozin) to reduce the risk of cardiovascular death and hospitalization for heart failure in adults.
-
Aspirin is linked with increased risk of heart failure
WorldPharmaNews
November 24, 2021
Aspirin use is associated with a 26% raised risk of heart failure in people with at least one predisposing factor for the condition. That’s the finding of a study published today in ESC Heart Failure, a journal of the European Society of Cardiology (ESC).
-
FDA grants priority review to Boehringer-Lilly’s Jardiance for heart failure
Pharmaceutical-Technology
November 15, 2021
Boehringer Ingelheim Pharmaceuticals and Eli Lilly have obtained the US Food and Drug Administration (FDA) priority review for Jardiance (empagliflozin) to potentially treat heart failure...
-
Why Water Is Key to Your Heart's Health
drugs
August 25, 2021
Everyone knows that drinking plenty of water every day can improve your health in a myriad of ways, but here's a lesser-known benefit: New research suggests that middle-aged adults can lower their long-term risk for heart failure by simply drinking enough
-
Can You Exercise Your A-fib Away?
drugs
August 25, 2021
Millions of Americans live with a common abnormal heart rhythm known as atrial fibrillation (a-fib), but new research suggests that exercise might ease the severity of the condition.
-
AHA News: She Had a Baby. Then Emergency Heart Surgery. And a Stroke. Then, a New Heart.
drugs
July 30, 2021
In her third trimester, Kristy Novillo struggled to give tours of the Redmond, Washington, child care center where she worked as a director. Walking and talking at the same time left her out of breath.
-
MSD, Bayer’s heart failure med Verquvo gains EU approval
pharmatimes
July 23, 2021
The European Commission (EC) has approved MSD and Bayer’s Verquvo for the treatment of symptomatic chronic heart failure in patients with reduced ejection fraction.
-
Pig Study Could Lead to Gene Therapy to Prevent Heart Failure
drugs
July 02, 2021
A gene therapy aimed at freeing the heart's capacity for self-repair has shown early promise in an animal study.